Xconomy’s Digital Events →
Stromedix was acquired by Biogen Idec in February 2012
Sponsored · Video
A Fireside Chat with Biocom President & CEO Joe Panetta
Sponsored · Whitepaper
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.